181 related articles for article (PubMed ID: 27546605)
1. Factors for tumor progression in patients with skull base chordoma.
Wang L; Tian K; Wang K; Ma J; Ru X; Du J; Jia G; Zhang L; Wu Z; Zhang J
Cancer Med; 2016 Sep; 5(9):2368-77. PubMed ID: 27546605
[TBL] [Abstract][Full Text] [Related]
2. Factors for Overall Survival in Patients with Skull Base Chordoma: A Retrospective Analysis of 225 Patients.
Tian K; Zhang H; Ma J; Wang K; Ru X; Du J; Jia G; Zhang L; Wu Z; Zhang J; Wang L
World Neurosurg; 2017 Jan; 97():39-48. PubMed ID: 27671886
[TBL] [Abstract][Full Text] [Related]
3. High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas.
Ma J; Tian K; Du J; Wu Z; Wang L; Zhang J
J Neurosurg; 2019 Jan; 132(1):140-149. PubMed ID: 30641849
[TBL] [Abstract][Full Text] [Related]
4. Effect comparisons among treatment measures on progression-free survival in patients with skull base chordomas: a retrospective study of 234 post-surgical cases.
Wang L; Tian K; Ma J; Wang K; Jia G; Wu Z; Zhang L; Zhang J
Acta Neurochir (Wien); 2017 Oct; 159(10):1803-1813. PubMed ID: 28699066
[TBL] [Abstract][Full Text] [Related]
5. Skull base chordomas: clinical outcome in a consecutive series of 45 patients with long-term follow-up and evaluation of clinical and biological prognostic factors.
Boari N; Gagliardi F; Cavalli A; Gemma M; Ferrari L; Riva P; Mortini P
J Neurosurg; 2016 Aug; 125(2):450-60. PubMed ID: 26745472
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.
Wang L; Wu Z; Tian K; Wang K; Li D; Ma J; Jia G; Zhang L; Zhang J
J Neurosurg; 2017 Dec; 127(6):1257-1267. PubMed ID: 28059654
[TBL] [Abstract][Full Text] [Related]
7. SNF5 as a prognostic factor in skull base chordoma.
Li M; Zhai Y; Bai J; Wang S; Gao H; Li C; Gui S; Du J; Zhang Y
J Neurooncol; 2018 Mar; 137(1):139-146. PubMed ID: 29222701
[TBL] [Abstract][Full Text] [Related]
8. Male sex as a risk factor for the clinical course of skull base chordomas.
Rachinger W; Eigenbrod S; Dützmann S; Simon M; Feigl GC; Kremenevskaja N; Kretzschmar H; Zausinger S; Kreth FW; Thon N; Tonn JC
J Neurosurg; 2014 Jun; 120(6):1313-20. PubMed ID: 24405075
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical factors and PDGFR-β in predicting prognosis of patients with clival chordoma.
Zhai Y; Bai J; Wang S; Gao H; Li M; Li C; Gui S; Zhang Y
J Neurosurg; 2018 Dec; 129(6):1429-1437. PubMed ID: 29303447
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Transforming Growth Factor-α and Ki-67 for the Prognosis of Skull Base Chordoma.
Zhang S; Bai J; Li M; Zhai Y; Wang S; Liu Q; Li C; Gui S; Zhang Y
World Neurosurg; 2019 Sep; 129():e199-e206. PubMed ID: 31125781
[TBL] [Abstract][Full Text] [Related]
11. Disease outcomes for skull base and spinal chordomas: a single center experience.
Ahmed R; Sheybani A; Menezes AH; Buatti JM; Hitchon PW
Clin Neurol Neurosurg; 2015 Mar; 130():67-73. PubMed ID: 25590662
[TBL] [Abstract][Full Text] [Related]
12. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
[TBL] [Abstract][Full Text] [Related]
13. Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma.
Wei W; Wang K; Liu Z; Tian K; Wang L; Du J; Ma J; Wang S; Li L; Zhao R; Cui L; Wu Z; Tian J
Radiother Oncol; 2019 Dec; 141():239-246. PubMed ID: 31668985
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas-106 cases review in one institution.
Wu Z; Zhang J; Zhang L; Jia G; Tang J; Wang L; Wang Z
Neurosurg Rev; 2010 Oct; 33(4):451-6. PubMed ID: 20668904
[TBL] [Abstract][Full Text] [Related]
15. Proposal and Validation of a Basic Progression Scoring System for Patients with Skull Base Chordoma.
Ma JP; Tian KB; Wang L; Wang K; Li D; Yang Y; Du J; Ru XJ; Zhang LW; Wu Z; Zhang JT
World Neurosurg; 2016 Jul; 91():409-18. PubMed ID: 27132181
[TBL] [Abstract][Full Text] [Related]
16. Nomogram for Individualized Prediction and Prognostic Factors for Survival in Patients with Primary Spinal Chordoma: A Population-Based Longitudinal Cohort Study.
Huang JF; Chen D; Sang CM; Zheng XQ; Lin JL; Lin Y; Ni WF; Wang XY; Li YM; Wu AM
World Neurosurg; 2019 Aug; 128():e603-e614. PubMed ID: 31054340
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological implications of TIM3
Zhou J; Jiang Y; Zhang H; Chen L; Luo P; Li L; Zhao J; Lv F; Zou D; Zhang Y; Jing Z
Cancer Immunol Immunother; 2019 Jul; 68(7):1157-1169. PubMed ID: 31197461
[TBL] [Abstract][Full Text] [Related]
18. Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma.
Freeman JL; DeMonte F; Al-Holou W; Gidley PW; Hanna EY; Kupferman ME; Su SY; Raza SM
Acta Neurochir (Wien); 2018 Apr; 160(4):731-740. PubMed ID: 29270681
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting recurrence after resection of clival chordoma using variable surgical approaches and radiation modalities.
Jahangiri A; Chin AT; Wagner JR; Kunwar S; Ames C; Chou D; Barani I; Parsa AT; McDermott MW; Benet A; El-Sayed IH; Aghi MK
Neurosurgery; 2015 Feb; 76(2):179-85; discussion 185-6. PubMed ID: 25594191
[TBL] [Abstract][Full Text] [Related]
20. Skull base chordoma.
Mendenhall WM; Mendenhall CM; Lewis SB; Villaret DB; Mendenhall NP
Head Neck; 2005 Feb; 27(2):159-65. PubMed ID: 15641104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]